Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
LSL Pharma Group Inc ( (TSE:LSL) ) has shared an announcement.
LSL Pharma Group Inc. announced a semi-annual interest payment on its unsecured convertible debentures, with a reduced interest rate following the acquisition of Dermolab Pharma Ltd. This acquisition, which complements LSL Pharma’s existing offerings and generated significant revenue, allows the company to lower the interest rate from 11% to 10%, reflecting positively on its financial strategy and potentially benefiting stakeholders.
More about LSL Pharma Group Inc
LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company specializing in the development, manufacturing, and marketing of high-quality sterile ophthalmic pharmaceuticals, as well as cosmetics, pharmaceuticals, and natural health products in solid, semi-solid, and liquid forms.
YTD Price Performance: -20.24%
Average Trading Volume: 50,036
Technical Sentiment Signal: Buy
Find detailed analytics on LSL stock on TipRanks’ Stock Analysis page.